Winter Olympics Order and Independent FIMS Validation
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
4 September 2025
Winter Olympics Order and International Sports Medicine Validation
Key Highlights
• Major Olympic Order: HITIQ to supply 100 PROTEQT™ instrumented
mouthguards for athlete safety monitoring at the Winter Olympics.
• Elite Validation: Success in Olympic trials highlights PROTEQT™'s comfort,
usability, and advanced analytics.
• Independent Assessment: PROTEQT™ is being evaluated by the International
Federation of Sports Medicine (FIMS) for validation and implementation in highrisk sports.
• Expert Leadership: Programs led by Professor Yannis Pitsiladis, IOC Medical and
Scientific Commission Member, Chair of the Scientific Commission of FIMS, and
Chair of the European Federation of Sports Medicine.
• Global Momentum: Growing recognition of PROTEQT™ as a concussion and
head/neck protection solution across elite markets.
Winter Olympics Programme
Following a successful trial, HITIQ Limited (ASX: HIQ) (HITIQ or the Company) HITIQ has secured an
order for 100 PROTEQT™ units to support athlete safety monitoring at the Winter Olympics. The
system was selected for its comfort, intuitive design, ease of use, and advanced analytics capabilities,
which deliver precise head impact data to support physiological assessments and proactive safety
measures.
This two-year Winter Olympics agreement provides important validation of PROTEQT™'s capabilities at
the elite level. The programme is led by Professor Yannis Pitsiladis, an internationally recognised sports
scientist and member of the International Olympic Committee's Medical and Scientific Commission,
who will integrate the technology into comprehensive monitoring protocols to enhance athlete
wellbeing. In addition to concussion detection, the system will be used to support protection of the
head and neck during high-risk and extreme winter sports disciplines.
International Federation of Sports Medicine (FIMS) Assessment
PROTEQT™is currently being independently assessed by the International Federation of Sports
Medicine (FIMS), the world's leading organisation for sports medicine, representing over 120 national
federations and 30,000 medical professionals globally. FIMS is evaluating the system for validation and
potential implementation in high-risk sports, including contact, winter, and extreme sports disciplines.
This independent assessment highlights PROTEQT™'s potential as a standardised athlete safety
solution across elite and community sport worldwide.
Leadership Commentary
Earl Eddings, Executive Chair, HITIQ:
"These achievements mark an important step for HITIQ. Securing 100 units for the Winter Olympics
validates our technology at the highest level of competition. With the ongoing FIMS assessment, we
are seeing adoption and recognition across multiple levels of competition."
Professor Yannis Pitsiladis, IOC Medical and Scientific Commission Member, Chair of the Scientific
Commission of FIMS, and Chair of the European Federation of Sports Medicine:
"The PROTEQT™ system represents an important advancement in athlete safety. Real-time head
impact data integrates effectively with our assessment protocols, enabling more sensitive monitoring
and timely interventions to protect athlete wellbeing. Importantly, its application extends beyond
concussion management to also support protection of the head and neck in extreme sports
environments. Its deployment at the Winter Olympics and assessment by the International Federation
of Sports Medicine (FIMS) demonstrates its potential for broader adoption in high-risk sports globally."
Strategic Impact
The combination of Olympic adoption and independent FIMS evaluation represents a significant
commercial milestone for HITIQ. Production capacity is being scaled with a view to supporting growing
global demand across elite sports markets.
Authorised for release by the Board of HITIQ Limited
For further information, contact: investors@hitiq.com
About HITIQ
HITIQ Limited (ASX: HIQ) develops concussion management and athlete safety technology for sport,
clinical, and research applications worldwide. The company combines smart mouthguards and
analytics platforms to deliver data-driven safety solutions.
About PROTEQT™
PROTEQT™is HITIQ's concussion management and athlete safety solution that delivers real-time head
impact data through an instrumented mouthguard and analytics platform. Co-developed with Shock
Doctor, PROTEQT™builds on HITIQ's proven Nexus technology, already in use within the Australian
Football League (AFL) and National Rugby League (NRL).
About Professor Yannis Pitsiladis
Professor Yannis Pitsiladis is a sports scientist and Professor at Hong Kong Baptist University. Since
2015, he has served as a member of the International Olympic Committee's Medical and Scientific
Commission. He is also Chair of the Scientific Commission of the International Federation of Sports
Medicine (FIMS) and Chair of the European Federation of Sports Medicine, contributing to global
initiatives to enhance athlete safety through advanced sensor technologies.
Share your feedback
Discover